Evidence map›Paper›PMID 28098344›Full record

ArticleThe Journal of physiology2017

Inhibition of oxytocin and vasopressin neuron activity in rat hypothalamic paraventricular nucleus by relaxin-3-RXFP3 signalling.

Alan Kania, Anna Gugula, Agnieszka Grabowiecka, Camila de Ávila, Tomasz Blasiak, Zenon Rajfur, Marian H Lewandowski, Grzegorz Hess, Elena Timofeeva, Andrew L Gundlach and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of physiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
6.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. Article
  3. Involvement of theFrontiers in neuroanatomy · 2021
    Article
  4. Article
  5. RLN3/RXFP3 Signaling in the PVN Inhibits Magnocellular Neurons via M-like Current Activation and Contributes to Binge Eating Behavior.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2020
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 3 countries.

Alan KaniaDepartment of Neurophysiology and Chronobiology, Institute of Zoology, Jagiellonian University, 30-387, Krakow, Poland.
Anna GugulaDepartment of Neurophysiology and Chronobiology, Institute of Zoology, Jagiellonian University, 30-387, Krakow, Poland.
Agnieszka GrabowieckaDepartment of Neurophysiology and Chronobiology, Institute of Zoology, Jagiellonian University, 30-387, Krakow, Poland.
Camila de ÁvilaFaculté de Médecine, Département de Psychiatrie et de Neurosciences, Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Québec, Université Laval, Québec, QC, Canada, G1V 0A6.
Tomasz BlasiakDepartment of Neurophysiology and Chronobiology, Institute of Zoology, Jagiellonian University, 30-387, Krakow, Poland.
Zenon RajfurFaculty of Physics, Astronomy and Applied Computer Science, Institute of Physics, Jagiellonian University, 30-348, Krakow, Poland.
Marian H LewandowskiDepartment of Neurophysiology and Chronobiology, Institute of Zoology, Jagiellonian University, 30-387, Krakow, Poland.
Grzegorz HessDepartment of Neurophysiology and Chronobiology, Institute of Zoology, Jagiellonian University, 30-387, Krakow, Poland.
Elena TimofeevaFaculté de Médecine, Département de Psychiatrie et de Neurosciences, Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Québec, Université Laval, Québec, QC, Canada, G1V 0A6.
Andrew L GundlachThe Florey Institute of Neuroscience and Mental Health, Parkville, VIC, 3052, Australia.ORCID 0000-0002-6066-9692
Anna BlasiakDepartment of Neurophysiology and Chronobiology, Institute of Zoology, Jagiellonian University, 30-387, Krakow, Poland.ORCID 0000-0002-4017-2988
Jagiellonian University · PLInstitut universitaire de cardiologie et de pneumologie de Québec · CAThe University of Melbourne · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

key pointsRelaxin-3 is a stress-responsive neuropeptide that acts at its cognate receptor, RXFP3, to alter behaviours including feeding. In this study, we have demonstrated a direct, RXFP3-dependent, inhibitory action of relaxin-3 on oxytocin and vasopressin paraventricular nucleus (PVN) neuron electrical activity, a putative cellular mechanism of orexigenic actions of relaxin-3. We observed a Gα ABSTRACT: The paraventricular nucleus of the hypothalamus (PVN) plays an essential role in the control of food intake and energy expenditure by integrating multiple neural and humoral inputs. Recent studies have demonstrated that intracerebroventricular and intra-PVN injections of the neuropeptide relaxin-3 or selective relaxin-3 receptor (RXFP3) agonists produce robust feeding in satiated rats, but the cellular and molecular mechanisms of action associated with these orexigenic effects have not been identified. In the present studies, using rat brain slices, we demonstrated that relaxin-3, acting through its cognate G-protein-coupled receptor, RXFP3, hyperpolarized a majority of putative magnocellular PVN neurons (88%, 22/25), including cells producing the anorexigenic neuropeptides, oxytocin and vasopressin. Importantly, the action of relaxin-3 persisted in the presence of tetrodotoxin and glutamate/GABA receptor antagonists, indicating its direct action on PVN neurons. Similar inhibitory effects on PVN oxytocin and vasopressin neurons were produced by the RXFP3 agonist, RXFP3-A2 (82%, 80/98 cells). In situ hybridization histochemistry revealed a strong colocalization of RXFP3 mRNA with oxytocin and vasopressin immunoreactivity in rat PVN neurons. A smaller percentage of putative parvocellular PVN neurons was sensitive to RXFP3-A2 (40%, 16/40 cells). These data, along with a demonstration of abundant peri-PVN and sparse intra-PVN relaxin-3-immunoreactive nerve fibres, originating from the nucleus incertus, the major source of relaxin-3 neurons, identify a strong inhibitory influence of relaxin-3-RXFP3 signalling on the electrical activity of PVN oxytocin and vasopressin neurons, consistent with the orexigenic effect of RXFP3 activation observed in vivo.

Indexed as

Signal TransductionAction PotentialsAnimalsGABA AntagonistsGTP-Binding Protein alpha Subunits, Gi-GoMaleNeuronsOxytocinParaventricular Hypothalamic NucleusPotassiumRatsRats, WistarReceptors, G-Protein-CoupledReceptors, PeptideRelaxinTetrodotoxinGABA AntagonistsGTP-Binding Protein alpha Subunits, Gi-GoOxytocinPotassiumReceptors, G-Protein-CoupledReceptors, PeptideRelaxinRXFP3 protein, ratTetrodotoxinVasopressinsoxytocinRXFP3 receptorsvasopressin

Identifiers

PMID28098344
PMCPMC5451722
OpenAlexW2578969393

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.